Search
Partnering_In_PAIN_0.pdf
Partnering_In_INFECTIOUS_1.pdf
Defining underserved communities_Infographic_230627.pdf
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
Partnering in Infectious Diseases MAY 2024 CORP_0.pdf
Supplier Training Deck - Invoice
Partnering with Boehringer Ingelheim MAY 2023 Corp
Defining underserved communities_Infographic_230627.pdf
Infographic_Defining underserved communities_230627.pdf
Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf
Partnering in Pain & Mobility MAY 2024 CORP_0.pdf
Boehringer_Ingelheim_auf_einen_Blick_2018.pdf
Boehringer Ingelheim Animal Health Business Unit Factsheet_2.pdf
WISDOM_Infographic_Final_Print Ready.pdf
About Our Business| Bioxcellence | Boehringer Ingelheim
BioXcellence, reliable contract development & manufacturing partner to the pharmaceutical industry. A trusted partner through the Lifecyle of your product.
Partnering with Boehringer Ingelheim at BIO-Europe 2024
Learn about partnering with Boehringer Ingelheim at BIO-Europe 2024 and how together we can accelerate innovation in human health
Partnering in Retinal Health HP OCTOBER 2024 CORP_1.pdf
Partnering with Boehringer Ingelheim HP OCTOBER 2024 CORP.pdf
Veronika Kohlbrenner
Veronika Kohlbrenner, Patient Safety Physician in Therapeutic Area Inflammation, tells us how she is able to work across different levels of the drug development process.
Phase 3 studies survodutide obesity and overweight
Phase 3 studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
Systemic sclerosis physician video
In this video Professor Chris Denton (Consultant Rheumatologist) discusses his experience diagnosing systemic sclerosis, also known as scleroderma
CPHI Survey
CPHI Survey